Healthcare Market Access

We provide holistic reports combining strategy and market evaluation with competitive intelligence (CI) to help pharmaceutical, medical device, and diagnostics firms and other life sciences or diagnostics players establish as well as improve their product presence in the face of intense market rivalry and price wars.

Get Started

Market Access in Healthcare

Before deciding about entering the market, changing prices, shifting product positioning, or implementing other strategic actions in response to the competitive landscape, companies in the life sciences and healthcare industries must thoroughly analyze the market and its subtleties.

No new or old company can predict how customers or decision-makers feel in any market. A business must be able to monitor market trends in real-time to ensure its goods are moving to the high-demand market instead of sitting in storage.

We have helped major Korean and Indonesian enterprises break into the American market and empowered small, family-owned medical diagnostics firms to expand into Western Europe. Our expanding network of international offices is a testament to our success and prominence in the marketplace.

Market Access Services for Healthcare

We assist you in answering these concerns before you even begin to schedule the procedure.

How big is the potential market for me right now, and will it expand or shrink at a specific time?
How can I use information and insights to learn about the interplay between payers, providers, and the distribution landscape?
How can I maximize my reimbursement wherever I may be?

How do I use market data to inform strategic decisions?
I do not understand why some of my competitors are outperforming me.
How can I ensure the payers receive the most money possible for my services, goods, and tools?

Healthcare Market Access Services We Offer

Drug and Device Market Sizing, Pricing, and Strategic Market Access Support

SGA covers both native English-speaking and non-English-speaking markets like the GCC, CIS, SEA, and LATAM.

Coverage of the U.S. and International Healthcare & Market Access Systems

SGA offers a 360° overview of healthcare and market access systems and tracks how the key country pricing systems work before planning your market entry or expansion.

Health Economics and Pricing

SGA has a team of experts who carry out systematic literature reviews, evaluate it, and advise why setting prices with health economics is not the same as defending prices with health economics in each market.

Payer Perception Toward Your Products

SGA measures the strength of your clinical profile and the ‘pricing power’ it affords you by conducting market surveys and primary research with the end users.

Establishing a Connection With the Payers

SGA uses evidence-based techniques to get the most accurate feedback while conducting pricing research with the stakeholders. Our insights are stronger and better as our pool size of customer interviewees is statistically significant and driven by our in-house panelists.

Analyzing Payer Behavior to Foresee Market Access

SGA analyzes historic payer behavior and current nuances as a powerful predictor and explainer of future pricing behavior. Our forecast models are customizable and data-driven and built by industry experts with over 15 years of experience in their specific fields.

Mapping International Pricing System

SGA’s global network helps you evaluate the impact of your product’s prices globally.

Implementing a Pricing and Market Access Strategy

Our team of experts supports your market access teams during the implementation phase and helps build a sustainable near-term roadmap.

Why SGA

Industry Leader

SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.

12+ Languages

Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).

Data-Driven Insights

With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.

End-To-End Solutioning

The in-house KOL capability of more than 700, along with the in-house capabilities of primary market research, financial research, data analytics, data engineering, IT, and ESG research and consulting, helps to present credible competitive information.

Who We Work With

Medical Devices

We support new product entries, competitive intelligence (CI), and market intelligence teams with relevant information.

Pharmaceuticals & Biopharma

We support pharma and biopharma market intelligence, strategy, sales, marketing, and R&D teams in developed and developing markets.

Mergers and Acquisition Analysis

We support M&A firms with product portfolio fitment analysis, patents and clinical trial data, pipeline analysis, and short listing of healthcare acquirer and acquire prospects.

Private Equity, Investment Banks, and Investor Community

We support financial firms with ad-hoc and white-labeled research comprising industry analysis, primary research, and CI intel from major markets.

Animal Health

We offer market intelligence on veterinary products and equipment and help mid-senior management with relevant data.

In Vitro Diagnostics

We track diagnostics kits, reagents, and equipment, which help marketing and sales teams with market penetration efforts. Our services are preferred by product managers and marketing leaders.

Life Sciences & Healthcare IT

We offer technology tracking services, market sizing and forecasting, and primary market research involving healthcare payers and providers and product launch information to life sciences & healthcare IT leaders of the world.

Life Sciences Consulting & Information Service Providers

We have run off-shored capability centers of ISPs, with a record of tracking >5,000 pharmaceutical companies and supporting their onshore teams to track markets and create analyses.